Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03352791 · ClinicalTrials.gov registry record · NA
The Dementia Symptom Management at Home Program Hospice Edition
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03352791: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT03352791 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03352791, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for this population and therefore have difficulty assisting patients and caregivers in maintaining quality of life leading to adverse patient outcomes, increased caregiver stress and burnout, and healthcare utilization. This study will utilize a cluster randomized controlled design with 6 care teams at a single study site to examine the ability of a multi-component evidence-based practice hospice care quality improvement program for registered nurses, social workers and chaplains to improve the quality of life and reduce healthcare utilization for persons with dementia and their informal caregiver.
Primary Outcome
pain assessment tool for use in persons with moderate to severe dementia who cannot provide reliable report, and will be used if the QDRS\>12
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL DSM-H Hospice Edition performance improvement program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-10-05 |
| Phase | NA |
Why NCT03352791 stopped before completion
NCT03352791 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03352791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03352791 about?
NCT03352791 is a clinical study titled "The Dementia Symptom Management at Home Program Hospice Edition". Alzheimer's Disease and Related Disorders (dementia) poses a significant challenge to our public health. While many persons with dementia are cared for by friends and family in the community with the assistance of home healthcare and hospice, most clinicians and agencies are ill prepared to care for...
What is the current status of trial NCT03352791?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-08-01. Estimated completion is 2018-10-05.
What interventions are being tested in trial NCT03352791?
The interventions under investigation include: Usual Care (BEHAVIORAL), DSM-H Hospice Edition performance improvement program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03352791?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03352791's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI